![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/article/aav-manufacturing-takes-center-stage-at-asgct24/
https://oxb.com/oxford-biomedica-plc-preliminary-results-for-the-year-ended-31-december-2023/
https://oxb.com/oxford-biomedica-provides-update-on-cdmo-services-including-new-commercial-agreement/
https://oxb.com/board-changes-following-transformation-to-pure-play-cdmo-business-model/
https://www.globenewswire.com//news-release/2024/03/05/2840274/0/en/Update-to-Medium-Term-Financial-Guidance-and-2023-Trading-and-Notice-of-Preliminary-Results.html
https://www.globenewswire.com/news-release/2024/01/29/2818732/0/en/Oxford-Biomedica-completes-acquisition-of-ABL-Europe.html
https://www.globenewswire.com//news-release/2024/01/23/2813925/0/en/Oxford-Biomedica-is-hosting-a-free-webinar-to-share-clients-success-stories-in-viral-vector-manufacturing.html
https://www.globenewswire.com//news-release/2023/12/07/2792389/0/en/Business-Update.html
https://www.fiercepharma.com/manufacturing/oxford-biomedica-shells-out-15m-euros-acquire-abl-europe
https://www.globenewswire.com//news-release/2023/12/04/2789896/0/en/Oxford-Biomedica-signs-agreement-to-acquire-ABL-Europe-from-Institut-M%C3%A9rieux-consolidating-position-as-a-global-pure-play-CDMO.html